Roche to buy US biotech firm InterMune for $8.3 billion

17:21 PM | August 24, 2014 | Natasha Alperowicz

Roche (Basel) said today that it has agreed to acquire InterMune (Brisbane, CA), a biotech company focused on R&D and commercializing therapies in pulmonology and orphan fibrotic diseases, for $8.3...